XBIT 7.5 (+1.49%)
CA98400H1029BiotechnologyBiotechnology

XBiotech (XBIT) Financial Metrics

This table shows a selected set of financial data points of XBiotech (XBIT). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 -0.81 0 -4.96 121.75M -0.1 0 -19.09M -37.66M -24.56M 200.02M
2022 -1.08 0 -3.25 106.84M -0.13 4.01M -15.41M -29.08M -32.9M 157.31M
2021 -0.58 22.46 -19.2 334.38M -0.06 18.39M 65.92M -21.72M -17.41M 236.98M
2020 -0.36 0 -42.99 482.39M -0.02 44M -68.88M -19.53M -11.22M 237.37M
2019 17.17 0 1.09 726.92M 1.55 0 -18.47M -27.98M 668.63M 714.59M
2018 -0.59 0 -8.6 181.89M -0.39 0 -16.66M -18.71M -21.14M 15.82M
2017 -0.95 0 -4.15 137.41M -0.51 0 -35.05M -31.67M -33.15M 31.77M
2016 -1.63 0 -6.22 327.92M -0.6 0 -59.93M -52.06M -52.76M 34.32M
2015 -1.22 0 -8.93 334.82M -0.44 0 -43.7M -36.78M -37.48M 91.05M
2014 -0.68 0 0 0 -0.59 0 -13.1M -21.06M -21.72M 57.33M
2013 -0.31 0 0 0 -1.02 0 -8.97M -9.14M -9.93M 7.24M
2012 -0.48 0 0 0 0 0 -12.18M -14.21M -15.16M 4.17M

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.